Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (56665)	7/27/2000 12:45:44 PM
From: Taki	Respond to of 150070

STGI up.LOCH update below. =========================================================== By: Fdotdr $$$$ Reply To: None Thursday, 27 Jul 2000 at 12:00 PM EDT Post # of 100469 Update from Loch's website: lochharris.com VAMMP PROTOTYPE PHOTOS REVEALED PRIOR TO SPIE CONVENTION Chemical Detection Technology, Inc. (ChemTech), a subsidiary of Loch Harris, Inc. (OTCBB: LOCH) has released the first photographs of its VAMMP prototype. A photo of the VAMMP arrangement is accompanied by a picture of the fluorometer which acquires the basic chemical signature information required for mapping and measurement of constituents in a closed environment. The VAMMP photos are being made public in advance of its demonstration at the 45th annual meeting of The International Society for Optical Engineering (SPIE) in San Diego, Calif. As configured, VAMMP is designed to provide real-time data, noninvasively, in sealed semiconductor processing equipment. "We feel VAMMP should provide a unique and much needed service to the semiconductor fabs," said Dr. Henry Blair, chief scientist for ChemTech. "Current techniques, analyzing samples extracted from the chamber, are both invasive and time consuming. VAMMP's potential to acquire the same data quickly and without disturbing the process environment may greatly enhance yields," said Blair. "The semiconductor applications are only one of several iterations possible," added ChemTech and Loch Harris CEO, Rodney Boone. "Outside institutions and agencies have contacted ChemTech regarding environmental monitoring, drug detection, antiterrorism systems and food and drug process monitoring." VAMMP probe is shown on the left. This unit mounts on the process chamber. The electronic module is on the right. The module can be mounted remotely from the process chamber, thus eliminating equipment clutter at the production line. The keys are added as a scale reference. ChemTech's state of the art fluorometer provides signature data for the VAMMP system. The data is acquired by, and stored on the fluorometer computer and added to the VAMMP identification database. Both of ChemTech's current developments, the prototype configuration of VAMMP and the ELF, will be on exhibit at the SPIE event at the San Diego Convention Center. The exhibit hall is available to the general public Aug. 1 through Aug. 3 from 10 a.m. to 5 p.m. The ChemTech developers and company representatives will be on hand to demonstrate the technology and answer questions during exhibition hours. SPIE is a nonprofit professional society dedicated to advancing research, engineering and applications in optics, photonics, imaging and electronics. For more information on the SPIE meeting visit their website at spie.org. ELF, an acronym for Eliminate Landmines Forever, is an x-ray based device designed to be operated by a two-person team to detect and identify landmines and unexploded ordnance at a forward looking range of two meters. VAMMP, which is an acronym for VAcuum Multi-constituent Monitor of Plasma, uses an ultra-violet-based light source to monitor plasma in the manufacture of semiconductors. For more information about ChemTech's ELF and VAMMP, visit the Loch Harris web site at lochharris.com. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, regulatory approval processes, the impact of competitive products or other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. =================================================